Metal‐Doping Strategy for Carbon‐Based Sonosensitizer in Sonodynamic Therapy of Glioblastoma
Advanced Science · 2024
DOI: 10.1002/advs.202404230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Mingming Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering (Suzhou), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, Chin…. Hauptthemen laut MEDLINE: Glioblastoma, Carbon, Ultrasonic Therapy, Brain Neoplasms. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is the most common primary malignant brain tumor and known for its challenging prognosis. Sonodynamic therapy (SDT) is an innovative therapeutic approach that shows promise in tumor elimination by activating sonosensitizers with low‐intensity ultrasound. In this study, a novel sonosensitizer is synthesized using Cu‐doped carbon dots (Cu‐CDs) for the sonodynamic treatment of GBM. Doping with copper transforms the carbon dots into a p–n type semiconductor having a bandgap of 1.58 eV, a prolonged lifespan of 10.7 µs, and an improved electron‐ and hole‐separation efficiency. The sonodynamic effect is efficiency enhanced. Western blot analysis reveals that the Cu‐CDs induces a biological response leading to cell death, termed as cuproptosis. Specifically, Cu‐CDs upregulate dihydrosulfanyl transacetylase expression, thereby establishing a synergistic therapeutic effect against tumor cell death when combined with SDT. Furthermore, Cu‐CDs exhibit excellent permeability through the blood‐brain barrier and potent anti‐tumor activity. Importantly, the Cu‐CDs effectively impede the growth of glioblastoma tumors and prolong the survival of mice bearing these tumors. This study provides support for the application of carbon‐based nanomaterials as sonosensitizers in tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Engineering (Suzhou), Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230026, China.
- CAS Key Laboratory of Biomedical Diagnostics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Science (CAS), Suzhou, 215163, China.
ORCID-Profile: Wen-Fei Dong
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Innovation and Entrepreneurship Team of Jiangsu Province
- Natural Science Foundation of Jiangsu Province
- of China
- Youth Innovation Promotion Association of CAS
- National Key Research and Development Program of China
Zitieren
APA
Cheng, M., Liu, Y., You, Q., Lei, Z., Ji, J., Zhang, F., Dong, W. F., & Li, L. (2024). Metal‐Doping Strategy for Carbon‐Based Sonosensitizer in Sonodynamic Therapy of Glioblastoma. Advanced Science. https://doi.org/10.1002/advs.202404230
Vancouver
Cheng M, Liu Y, You Q, Lei Z, Ji J, Zhang F, et al. Metal‐Doping Strategy for Carbon‐Based Sonosensitizer in Sonodynamic Therapy of Glioblastoma. Advanced Science. 2024. doi:10.1002/advs.202404230
BibTeX
@article{Cheng2024,
author = {Cheng, Mingming and Liu, Yan and You, Qiannan and Lei, Zhubing and Ji, Jiajian and Zhang, Fan and Dong, Wen-Fei and Li, Li},
title = {Metal‐Doping Strategy for Carbon‐Based Sonosensitizer in Sonodynamic Therapy of Glioblastoma},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202404230}
}
EUVIMED